🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’ve got a massive problem brewing… The global antidepressants market is projected to more than double—from $17.8 billion in 2024 to a staggering $37.7 billion by 2034. 💊💰 In 2024 alone, North America led the way with 42.6% of the market—bringing in $7.6 billion in sales.

Does pharma sprinkle "commercially sensitive information" into drug protocol docs to later block public access to efficacy and safety data? Or is their "commercially sensitive" claim pure fiction? "Common sense suggests drug company commercial interests should never over-ride

This is an excellent webinar about #SSRI tapering. Most healthcare professionals remain unaware of the slow process of safe tapering, and that for some people, getting off #depression pills is a worse experience than what they experienced before initially being prescribed the

Just as #SouthDakota's Badlands hide sudden drop-offs, #akathisia can strike without warning. Today's new billboards in the Mount Rushmore state reflect MISSD's "50 in 5" initiative. 50 states. 5 years. 1 mission: Raise awareness to save lives. einpresswire.com/article/829561…

Vincent & Yoko, parents of Romain, speak up about their son's prescribed demise in hope that others might be safer and better informed.

We support our friends in Ireland. Every country needs an iatrogenic suicide verdict. Akathisia-induced deaths are NOT traditional deaths of despair.

This is a must-listen podcast that adeptly touches on several aspects that fuel the crisis of med-induced harm, including iatrogenic violence and #suicide. From ghostwritten journals and misguided polypharmacy to teens dying after misdiagnosed DSM labels, SSRI prescriptions and

Medication-induced suicide isn’t only linked to akathisia, psychosis, or delirium. Iatrogenic deaths can also result from enduring adverse effects—like emotional and physical numbness—that strip away a person’s ability to feel, connect, or function in ways they did prior to

#SSRI w/drawal is real & skyrocketing—yet still downplayed by pharma & prescribers. Reviews like Kalfas’s rely on short-term trials, just like the SSRI clinical trials. These drugs weren’t tested or approved for long-term use—yet many are told to consume them forever “like taking

It's beyond the pale to think SSRI w/drawal problems impact few people & are short term. This "study" and Dr. Roger McFillin's recent podcast with a Columbia U psychiatrist who was unfamiliar with Maudsley guidelines, is troubling. maudsley-prescribing-guidelines.co.uk

Another powerful video by Bob 'Fiddy' Fiddaman💜🇵🇦 highlighting the real-world experiences often left out of the antidepressant conversation. The public deserves a balanced discussion—not just the familiar “works for me” or “saved millions” soundbites.

The risk of congenital cardiac malformations has been downplayed to the detriment of mothers-to-be and women who are trying to get pregnant. Many are taking #SSRIs prior to realizing they are pregnant, others are told that there's no risk...

Some "people who experienced long-term withdrawal suffered for an average of eight years." It should be very concerningto medical system and the public that there are tens of millions of people walking around on drugs whose long-term exposure and withdrawal effects we do not

Approximately 5% of pregnant women take an SSRI for depression. But SSRI use during pregnancy has been linked in observational studies to birth defects, miscarriages, and neurological and behavioral challenges in childhood. On Monday, July 21 at 10 a.m. ET, we’ll be hosting an

When the healthcare system contributes to a tragedy, families deserve truth—not silence. Blaming victims of iatrogenesis for their prescribed demise is morally wrong, perpetuates stigma & causes more medical harm. We support Stephanie & Jake’s Amendment. Reforms to the Coroner’s